These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11652306)

  • 1. The cure that killed.
    Thompson L
    Discover; 1994 Mar; 15(3):56-62. PubMed ID: 11652306
    [No Abstract]   [Full Text] [Related]  

  • 2. Harm to research subjects will now lead to new federal regulations.
    Maloney DM
    Hum Res Rep; 1994 Dec; 9(12):1-3. PubMed ID: 11654161
    [No Abstract]   [Full Text] [Related]  

  • 3. Mandating research with children.
    Baylis F
    IRB; 1999; 21(1):10-1. PubMed ID: 11657966
    [No Abstract]   [Full Text] [Related]  

  • 4. IRB review of adverse events in investigational drug studies.
    Prentice ED; Gordon B
    IRB; 1997; 19(6):1-4. PubMed ID: 11656910
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA seeks public comment on informed consent rules in combat situations.
    Hastings Cent Rep; 1997; 27(5):43. PubMed ID: 11645003
    [No Abstract]   [Full Text] [Related]  

  • 6. Despite "clinical hold," subjects have right to keep getting experimental drug: Dahl v. HEM Pharmaceuticals Corporation (Part III).
    Maloney DM
    Hum Res Rep; 1996 Feb; 11(2):4-5. PubMed ID: 11654437
    [No Abstract]   [Full Text] [Related]  

  • 7. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
    Weijer C
    IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
    [No Abstract]   [Full Text] [Related]  

  • 8. New policy on research with children is part of trend toward including more research subjects.
    Maloney DM
    Hum Res Rep; 1998 May; 13(5):1-2. PubMed ID: 11657189
    [No Abstract]   [Full Text] [Related]  

  • 9. And then the patients suddenly started dying: how NIH missed warning signs in drug test.
    Schwartz J
    Washington Post; 1993 Sep; ():A1, A8-9. PubMed ID: 11646989
    [No Abstract]   [Full Text] [Related]  

  • 10. Women in clinical trials: concluding remarks.
    Buc NL
    Food Drug Law J; 1993; 48(2):223-6. PubMed ID: 11653146
    [No Abstract]   [Full Text] [Related]  

  • 11. International research agreement leads to new U.S. guidelines.
    Maloney DM
    Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182
    [No Abstract]   [Full Text] [Related]  

  • 12. After deaths, F.D.A. is proposing stiffer rules on drug experiments.
    Hilts PJ
    N Y Times Web; 1993 Nov; ():A1, C6. PubMed ID: 11647958
    [No Abstract]   [Full Text] [Related]  

  • 13. Research compliance changes will affect rules on protection of human subjects.
    Maloney DM
    Hum Res Rep; 1999 May; 14(5):1-2. PubMed ID: 11657776
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal drug trial raises questions about 'informed consent'.
    Altman LK
    N Y Times Web; 1993 Oct; ():C3. PubMed ID: 11647940
    [No Abstract]   [Full Text] [Related]  

  • 15. Proposal on waiver of informed consent poses major issues for research ethics.
    Maloney DM
    Hum Res Rep; 1997 Sep; 12(9):1-3. PubMed ID: 11660533
    [No Abstract]   [Full Text] [Related]  

  • 16. Federal report says protection of human subjects is threatened by numerous factors.
    Maloney DM
    Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
    [No Abstract]   [Full Text] [Related]  

  • 17. Federal agency keeps review committee after public comments support continuation.
    Maloney DM
    Hum Res Rep; 1997 Jan; 12(1):1-2. PubMed ID: 11654603
    [No Abstract]   [Full Text] [Related]  

  • 18. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
    Dunbar MM
    Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
    [No Abstract]   [Full Text] [Related]  

  • 19. If a subject incurs obligations and carries them out, then consent is a contract: Dahl v. HEM Pharmaceuticals (Part II).
    Maloney DM
    Hum Res Rep; 1996 Jan; 11(1):4-5. PubMed ID: 11653221
    [No Abstract]   [Full Text] [Related]  

  • 20. A drug company report: what is the same and what is changing with respect to inclusion/exclusion of women in clinical trials.
    Goldmann BJ
    Food Drug Law J; 1993; 48(2):169-74. PubMed ID: 11653139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.